Related Experiment Video

Updated: May 29, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Toll-like receptors are potential therapeutic targets in rheumatoid arthritis

Siamak Sandoghchian Shotorbani1, Zhao-Liang Su, Hua-Xi Xu

  • 1Siamak Sandoghchian Shotorbani, Zhao-Liang Su, Hua-Xi Xu, Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang 212013, Jiangsu Province, China.

World Journal of Biological Chemistry
|September 14, 2011
PubMed

Insights

Toll-like receptors (TLRs) are key immune sensors involved in inflammation and disease. Targeting TLR signaling pathways may offer new therapeutic strategies for autoimmune conditions like rheumatoid arthritis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Toll-like receptors (TLRs) are pattern recognition receptors crucial for immune responses.
  • TLRs recognize endogenous alarmins from damaged cells, contributing to inflammatory diseases.
  • TLRs are implicated in various autoimmune diseases, including rheumatoid arthritis.

Purpose of the Study:

  • To explore the role of Toll-like receptor signaling in the pathogenesis of inflammatory and autoimmune diseases.
  • To investigate the potential of TLR signaling transducers as therapeutic targets.

Main Methods:

  • Review of existing literature on TLRs in immune response and disease.
  • Analysis of data linking TLR signaling to inflammatory conditions and autoimmune diseases.
  • Examination of the role of endogenous TLR ligands in disease initiation.

Main Results:

  • TLRs are involved in activating immune responses and the pathogenesis of inflammation, injury, and cancer.
  • Endogenous alarmins released by damaged or dying cells act as TLR ligands, driving inflammatory diseases.
  • Growing evidence suggests TLR signaling plays a role in rheumatoid arthritis.

Conclusions:

  • TLR signaling is a significant factor in initiating and perpetuating inflammatory diseases.
  • The precise involvement of TLRs in rheumatoid arthritis requires further comprehensive understanding.
  • TLR signaling transducers represent promising targets for future therapeutic interventions in autoimmune diseases.
Keywords:
Autoimmune diseaseInnate immunityPattern recognition receptorsRheumatoid arthritisToll-like receptors

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...